One dose of oral hexarelin protects chronic cardiac function after myocardial infarction

Peptides

Volumn 56, Issue , 2014, Pages 156-162

  Mao, Yuanjie ^a   Tokudome, Takeshi ^a   Kishimoto, Ichiro ^a   Otani, Kentaro ^a   Miyazato, Mikiya ^a   Kangawa, Kenji ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Cardiac function; Hexarelin; Myocardial infarction; Sympathetic nerve

Indexed keywords

ADRENALIN; DOPAMINE; HEXARELIN; NORADRENALIN; OLIGOPEPTIDE;

ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY LIGATION; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BODY WEIGHT; CONTROLLED STUDY; FEEDING; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART PROTECTION; HEART RATE VARIABILITY; LEFT CORONARY ARTERY; LUNG WEIGHT; MALE; MORTALITY; MOUSE; NONHUMAN; PARASYMPATHETIC FUNCTION; PRIORITY JOURNAL; SHAM PROCEDURE; TIBIA; ANIMAL; BLOOD; C57BL MOUSE; DRUG EFFECTS; HEART RATE; MYOCARDIAL INFARCTION; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; DOPAMINE; EPINEPHRINE; HEART RATE; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; NOREPINEPHRINE; OLIGOPEPTIDES;

EID: 84899806238     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2014.04.004     Document Type: Article

References (40)

1. A.C. Arnold, K. Isa, H.A. Shaltout, M. Nautiyal, C.M. Ferrario, and M.C. Chappell et al. Angiotensin-(1-12) requires angiotensin converting enzyme and AT1 receptors for cardiovascular actions within the solitary tract nucleus Am J Physiol Heart Circ Physiol 299 2010 H763 H771
2. G. Baldanzi, N. Filigheddu, S. Cutrupi, F. Catapano, S. Bonissoni, and A. Fubini et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT J Cell Biol 159 2002 1029 1037 (Pubitemid 36055757)
3. I. Bedendi, G. Alloatti, A. Marcantoni, D. Malan, F. Catapano, and C. Ghé et al. Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin Eur J Pharmacol 476 2003 87 95 (Pubitemid 37315540)
4. V. Bodart, M. Febbraio, A. Demers, N. McNicoll, P. Pohankova, and A. Perreault et al. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart Circ Res 90 2002 844 849 (Pubitemid 34633875)
5. V. De Gennaro Colonna, G. Rossoni, M. Bernareggi, E.E. Müller, and F. Berti Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin Eur J Pharmacol 334 1997 201 207 (Pubitemid 27451989)
6. R. Deghenghi, M.M. Cananzi, A. Torsello, C. Battisti, E.E. Muller, and V. Locatelli GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant and adult rats Life Sci 54 1994 1321 1328 (Pubitemid 24131424)
7. J.A. Ezekowitz, P. Kaul, J.A. Bakal, P.W. Armstrong, R.C. Welsh, and F.A. McAlister Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction J Am Coll Cardiol 53 2009 13 20
8. H.D. Falls, B.D. Dayton, D.G. Fry, C.A. Ogiela, V.G. Schaefer, and S. Brodjian et al. Characterization of ghrelin receptor activity in a rat pituitary cell line RC-4B/C J Mol Endocrinol 37 2006 51 62 (Pubitemid 44288605)
9. First International Study of Infarct Survival Collaborative Group Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1 Lancet 2 1986 57 66
10. E. Ghigo, E. Arvat, L. Gianotti, B.P. Imbimbo, V. Lenaerts, and R. Deghenghi et al. Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man J Clin Endocrinol Metab 78 1994 693 698 (Pubitemid 24083313)
11. J. Kamegai, H. Tamura, T. Shimizu, S. Ishii, A. Tatsuguchi, and H. Sugihara et al. The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content Endocrinology 145 2004 3731 3738 (Pubitemid 39037559)
12. I. Kishimoto, T. Tokudome, H. Hosoda, M. Miyazato, and K. Kangawa Ghrelin and cardiovascular diseases J Cardiol 59 2012 8 13
13. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 402 1999 656 660 (Pubitemid 129516334)
14. A.F. Leite-Moreira, and J.B. Soares Physiological, pathological and potential therapeutic roles of ghrelin Drug Discov Today 12 2007 276 288 (Pubitemid 46467484)
15. Y. Lin, K. Matsumura, M. Fukuhara, S. Kagiyama, K. Fujii, and M. Iida Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats Hypertension 43 2004 977 982 (Pubitemid 38579901)
16. V. Locatelli, G. Rossoni, F. Schweiger, A. Torsello, V. De Gennaro Colonna, and M. Bernareggi et al. Growth hormone-independent cardioprotective effects of hexarelin in the rat Endocrinology 140 1999 4024 4031 (Pubitemid 30647097)
17. Y. Ma, L. Zhang, J.N. Edwards, B.S. Launikonis, and C. Chen Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia/reperfusion injury through regulation of intracellular calcium PLoS ONE 7 2012 e35265
18. Y. Ma, L. Zhang, B.S. Launikonis, and C. Chen Growth hormone secretagogues preserve the electrophysiological properties of mouse cardiomyocytes isolated from in vitro ischemia/reperfusion heart Endocrinology 153 2012 5480 5490
19. Y. Mao, T. Tokudome, I. Kishimoto, K. Otani, H. Hosoda, and C. Nagai et al. Hexarelin treatment in male ghrelin knockout mice after myocardial infarction Endocrinology 154 2013 3847 3854
20. Y. Mao, T. Tokudome, K. Otani, I. Kishimoto, M. Miyazato, and K. Kangawa Excessive sympathoactivation and deteriorated heart function after myocardial infarction in male ghrelin knockout mice Endocrinology 154 2013 1854 1863
21. Y. Mao, T. Tokudome, K. Otani, I. Kishimoto, M. Nakanishi, and H. Hosoda et al. Ghrelin prevents incidence of malignant arrhythmia after acute myocardial infarction through vagal afferent nerves Endocrinology 153 2012 3426 3434
22. S. Marleau, M. Mulumba, D. Lamontagne, and H. Ong Cardiac and peripheral actions of growth hormone and its releasing peptides: relevance for the treatment of cardiomyopathies Cardiovasc Res 69 2006 26 35 (Pubitemid 41818969)
23. K. Matsumura, T. Tsuchihashi, K. Fujii, I. Abe, and M. Iida Central ghrelin modulates sympathetic activity in conscious rabbits Hypertension 40 2002 694 699 (Pubitemid 35278606)
24. N. Nagaya, J. Moriya, Y. Yasumura, M. Uematsu, F. Ono, and W. Shimizu et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure Circulation 110 2004 3674 3679 (Pubitemid 39665256)
25. N. Nagaya, M. Uematsu, M. Kojima, Y. Ikeda, F. Yoshihara, and W. Shimizu et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure Circulation 104 2001 1430 1435 (Pubitemid 32880158)
26. T. Nishiue, H. Tsuji, N. Tarumi, S. Tokunaga, K. Tamura, and M. Masaki et al. Heart rate variability and left ventricular dilatation early after myocardial infarction J Electrocardiol 32 1999 263 268 (Pubitemid 29380164)
27. P. Pacher, T. Nagayama, P. Mukhopadhyay, S. Bátkai, and D.A. Kass Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats Nat Protoc 3 2008 1422 1434
28. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, and T.M. Brown et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209 doi:10.1161/CIR.0b013e3182009701 [accessed 01.02.11]
29. D.O. Schwenke, T. Tokudome, I. Kishimoto, T. Horio, P.A. Cragg, and M. Shirai et al. One dose of ghrelin prevents the acute and sustained increase in cardiac sympathetic tone after myocardial infarction Endocrinology 153 2012 2436 2443
30. D.O. Schwenke, T. Tokudome, I. Kishimoto, T. Horio, M. Shirai, and P.A. Cragg et al. Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality Endocrinology 149 2008 5172 5176
31. T. Soeki, I. Kishimoto, D.O. Schwenke, T. Tokudome, T. Horio, and M. Yoshida et al. Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction Am J Physiol Heart Circ Physiol 294 2008 H426 H432
32. 2+ homeostasis of isolated adult rat ventricular myocytes Endocrinology 151 2010 4446 4454
33. M.G. Sutton, and N. Sharpe Left ventricular remodeling after myocardial infarction: pathophysiology and therapy Circulation 101 2000 2981 2988 (Pubitemid 30415891)
34. J.F. Thayer, S.S. Yamamoto, and J.F. Brosschot The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors Int J Cardiol 141 2010 122 131
35. J. Thireau, B.L. Zhang, D. Poisson, and D. Babuty Heart rate variability in mice: a theoretical and practical guide Exp Physiol 93 2008 83 94 (Pubitemid 350293971)
36. A. Tivesten, E. Bollano, K. Caidahl, V. Kujacic, X.Y. Sun, and T. Hedner et al. The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction Endocrinology 141 2000 60 66 (Pubitemid 32266065)
37. A. Torsello, E. Bresciani, G. Rossoni, R. Avallone, G. Tulipano, and D. Cocchi et al. Ghrelin plays a minor role in the physiological control of cardiac function in the rat Endocrinology 144 2003 1787 1792 (Pubitemid 36543316)
38. J.E. Udelson, R.D. Patten, and M.A. Konstam New concepts in postinfarction ventricular remodeling Rev Cardiovasc Med 4 2003 S3 S12
39. A.J. van der Lely, M. Tschöp, M.L. Heiman, and E. Ghigo Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin Endocr Rev 25 2004 426 457 (Pubitemid 38780667)
40. H.D. White, and D.P. Chew Acute myocardial infarction Lancet 372 2008 570 584